• OPEN AN ACCOUNT
Indian Indices
Nifty
25,149.85 -205.40
(-0.81%)
Sensex
82,500.47 -689.81
( -0.83%)
Bank Nifty
56,754.70 -201.30
( -0.35%)
Nifty IT
37,693.25 -683.40
( -1.78%)
Global Indices
Nasdaq
44,384.39 -287.26
(-0.64%)
Dow Jones
6,279.98 -21.48
(-0.34%)
Hang Seng
39,553.98 -92.38
(-0.23%)
Nikkei 225
8,941.12 -34.54
(-0.38%)
Forex
USD-INR
85.68 -0.05
(-0.06%)
EUR-INR
100.36 -0.05
(-0.05%)
GBP-INR
116.41 -0.07
(-0.06%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter
May 20,2025
Net profit of Syncom Formulations (India) rose 139.05% to Rs 17.69 crore in the quarter ended March 2025 as against Rs 7.40 crore during the previous quarter ended March 2024. Sales rose 99.65% to Rs 148.88 crore in the quarter ended March 2025 as against Rs 74.57 crore during the previous quarter ended March 2024.

For the full year,net profit rose 95.30% to Rs 49.43 crore in the year ended March 2025 as against Rs 25.31 crore during the previous year ended March 2024. Sales rose 76.55% to Rs 465.01 crore in the year ended March 2025 as against Rs 263.39 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales148.8874.57 100 465.01263.39 77
OPM %11.9212.63 -11.6411.25 -
PBDT24.5811.33 117 70.7038.70 83
PBT23.2910.03 132 65.5033.97 93
NP17.697.40 139 49.4325.31 95